INTRODUCTION

Mycoplasma genitalium (MG) is a recognised sexually transmitted
infection causing urethritis in men and women. There is a growing concern that M. genitalium could become an STI superbug due to its increasing resistance to first-line azithromycin (macrolides) and second-line moxifloxacin (fluoroquinolones) antibiotics. In Northern Ireland where routine testing for M. genitalium is extremely limited, the true knowledge of macrolide resistance is unknown therefore adherence to a syndromic approach for management of urethritis could facilitate the spread of resistance strains amongst sexual partners. The aim of this study was to obtain preliminary data on the prevalence and associated macrolide resistance of M. genitalium in male and female patients attending Genitourinary Medicine (GUM) clinic in Belfast using a commercially available assay. 
METHODS
